Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Inspira Technologies Oxy BHN L - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
IINN
Nasdaq
3845
https://inspira-technologies.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Inspira Technologies Oxy BHN L
Inspira™ Technologies Announces First in Human of HYLA™ Blood Sensor in Clinical Study
- Mar 22nd, 2023 12:30 pm
Inspira™ Technologies Receives Approval from Sheba Medical Center to Conduct Clinical Study of the HYLA™ Blood Sensor
- Feb 13th, 2023 2:30 pm
Inspira™ Technologies Granted Patent by U.S. Patent Office for the INSPIRA™ ART System's Convertible Dual Lumen Cannula Device and Method of Use
- Jan 23rd, 2023 2:30 pm
Diamond Equity Research Initiates Coverage on Inspira Technologies Ltd. (NASDAQ: IINN)
- Jan 10th, 2023 1:00 pm
Inspira™ Technologies Signs Strategic OEM Agreement with Terumo Cardiovascular
- Dec 28th, 2022 1:30 pm
Inspira™ Technologies Interview to Air on Bloomberg U.S. on the RedChip Money Report®
- Dec 22nd, 2022 2:00 pm
Inspira(TM) Technologies Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
- Dec 22nd, 2022 1:00 pm
Inspira™ Technologies Begins Manufacturing of the ALICE™ CPB Device, ahead of planned 2023 FDA submission
- Dec 20th, 2022 2:30 pm
Inspira™ Technologies Signs Agreement to Conduct Clinical Study of HYLA™ Blood Sensor
- Dec 14th, 2022 2:00 pm
Inspira™ Technologies Reports Third Quarter 2022 Financial Results
- Nov 23rd, 2022 9:01 pm
Inspira™ Technologies Signs a Strategic Agreement in Europe to potentially provide $26.1 for Deployment of 1,364 HYLA™ Blood Sensors
- Nov 22nd, 2022 2:00 pm
Inspira™ Technologies Granted Patent by the Israeli Patent Office for Key Safety Component for the INSPIRA™ ART System
- Nov 10th, 2022 1:30 pm
Inspira™ Technologies to Present Advanced Respiratory Solutions to Key International Leaders at the Annual iECOs Conference in Tel Aviv, Israel
- Nov 8th, 2022 2:00 pm
15 Best High Volume Penny Stocks to Buy Now
- Nov 3rd, 2022 9:00 pm
Inspira™ Technologies Performed HYLA™ Blood Sensor In-Vivo Study, in Preparation of Planned Human Studies
- Sep 7th, 2022 1:00 pm
Inspira™ Technologies to Present at the H.C. Wainwright 24th Annual Global Investor Conference
- Sep 1st, 2022 1:00 pm
Inspira™ Technologies Reports Second Quarter 2022 Financial Results
- Aug 11th, 2022 1:00 pm
Inspira™ Technologies Reveals Next Generation Liby™ System, an Extracorporeal Membrane Oxygenation System, Targeting a $531 Million Global ECMO Market
- Jul 11th, 2022 1:00 pm
Inspira™ Technologies Signs Strategic Agreement in U.S. to potentially provide $59 million for Inspira for deployment of 3,889 HYLA™ Blood Sensors
- Jul 7th, 2022 12:30 pm
Inspira stock soars, Peloton offers workers cash bonuses, Rivian deliveries more than triple in Q2
- Jul 6th, 2022 7:57 pm
Scroll